ABCG2 and exocrine pancreatic carcinoma: Using barasertib-resistant pancreatic carcinoma cell lines and microarray analysis, Guo et al., have shown that elevated expression of multi-drug resistant protein (MDR1) and breast cancer resistant protein (BCRP) is responsible for drug resistance and their expression could serve as a marker for barasertib sensitivity [160].